Dren Investigational Site

Fairfax, Virginia 22031

3 studies enrolling now · 3 studies all time

What they study most

Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes, Castrate Resistant Prostate Cancer, Cervical Cancer, Cutaneous PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Cytotoxic PTCL-NOS (CD8+ or CD56+ and Cytotoxic Marker), Endometrial Cancer, Enteropathy-Associated T-Cell Lymphoma, Extranodal NK/T Cell Lymphoma, Nasal Type, Gastric Cancer, Gastroesophageal-junction Cancer

Studies at this site

• A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas — Recruiting now
• A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas — Recruiting now
• A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes — Starting soon